CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract

Eur J Nutr. 2012 Jun;51(4):465-76. doi: 10.1007/s00394-011-0231-2. Epub 2011 Aug 6.

Abstract

Purpose: To evaluate the effect of cocoa flavonoids in breast cancer cells at the molecular level, a functional genomic analysis was performed using a polyphenolic cocoa extract (PCE) in MCF-7 and SKBR3 cell lines.

Methods: The expression profile of 84 genes included in the Stress & Toxicity PathwayFinder™ PCR Array was analyzed after PCE incubation for 24 h. mRNA and protein levels were analyzed by RT-PCR and western blot, respectively. Gel shift assays were used to evaluate DNA-protein complexes. Protein complexes were identified by co-immunoprecipitation. Cell viability was evaluated by MTT assays.

Results: Upon PCE incubation, 7 genes were overexpressed and 1 underexpressed in MCF-7 cells, whereas 9 genes were overexpressed in SKBR3 cells. Among the differentially expressed genes in both cell lines, cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) was chosen for further study. CYP1A1 mRNA and protein levels and enzymatic activity increased upon PCE incubation. CYP1A1 transcriptional activation by PCE was mediated through AhR binding to XRE elements within the CYP1A1 promoter in MCF-7 cells. A protein complex including AhR and ERα was detected. The combination of PCE with tamoxifen caused a synergistic cytotoxicity in both cell lines and was due to an increase in apoptosis in MCF-7 cells.

Conclusions: The interaction between ERα and AhR upon incubation with PCE leads to CYP1A1 induction in breast cancer cells. The synergy between PCE and non-cytotoxic tamoxifen concentrations opens the possibility for a combination therapy based on polyphenols from cocoa that increased tamoxifen efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / metabolism
  • Cacao / chemistry*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cytochrome P-450 CYP1A1 / biosynthesis*
  • Cytochrome P-450 CYP1A1 / genetics
  • Drug Synergism
  • Enzyme Induction / drug effects
  • Estrogen Receptor alpha / metabolism
  • Female
  • Flavonoids / analysis
  • Flavonoids / pharmacology*
  • Gene Expression Profiling
  • Humans
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • RNA, Messenger / metabolism
  • Receptors, Aryl Hydrocarbon / metabolism
  • Response Elements / drug effects
  • Seeds / chemistry
  • Selective Estrogen Receptor Modulators / pharmacology
  • Tamoxifen / pharmacology

Substances

  • AHR protein, human
  • Antineoplastic Agents, Phytogenic
  • Antioxidants
  • Basic Helix-Loop-Helix Transcription Factors
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Flavonoids
  • Plant Extracts
  • RNA, Messenger
  • Receptors, Aryl Hydrocarbon
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • CYP1A1 protein, human
  • Cytochrome P-450 CYP1A1